✦ LIBER ✦

Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as Prognostic Factors of Recurrence in T1 and T2 Laryngeal Carcinoma

✍ Scribed by Christian Sittel; Hans E. Eckel; Michael Damm; Ekkehard von Pritzbuer; Hans Martin Kvasnicka

Book ID: 110082329
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 98 KB
Volume: 110
Category: Article
ISSN: 0023-852X
DOI: 10.1097/00005537-200006000-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53, Ki67 and cyclin D1 as prognosticato

p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma

✍ D. Mielcarek-Kuchta; J. Olofsson; W. Golusinski 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 442 KB

p53 and ki67 Expression as Prognostic Fa

p53 and ki67 Expression as Prognostic Factors for Cancer-Related Survival in Stage T1 Transitional Cell Bladder Carcinoma

✍ Andrés Rodrı́guez-Alonso; Salvador Pita-Fernández; Joaquı́n González-Carreró; Jo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 395 KB

Prognostic Factors in Stage T1 Grade 3 B

Prognostic Factors in Stage T1 Grade 3 Bladder Cancer Survival: The Role of G1–S Modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and Proliferation Index (ki67-MIB1)

✍ A. Lopez-Beltran; R.J. Luque; J. Alvarez-Kindelan; A. Quintero; F. Merlo; J.C. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 129 KB

P251 Ki-67, cytokeratin depth of invasio

P251 Ki-67, cytokeratin depth of invasion and microvessel density: prognostic importance in T1/T2 oral squamous cell carcinoma

✍ G. Giardina; E. Maiorano; A. Napoli; P. Sisto; M. Petruzzi; G. Favia 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 61 KB

Protein expression of p53, bcl-2, and KI

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

✍ Judd W. Moul; Marie-Claude Bettencourt; Isabell A. Sesterhenn; F.K. Mostofi; Dav 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 716 KB

Proliferating cell nuclear antigen and p

Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2MO prostatic adenocarcinoma

✍ Satu L. B. Vesalainen; Pertti K. Lipponen; Martti T. Talja; Esko M. Alhava; Kari 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 784 KB

The expression of proliferating cell nuclear antigen and p53 protein was analysed by immunocy-tochemical methods (PC 10, CM I antisera) in I39 patients with TI -2M0 prostatic adenocarcinomas followed-up for > 12 years. p53 protein was expressed in 2 I ( IS0/o) tumours ( 15%). the fraction of positiv